These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15786392)

  • 21. Allograft diabetic nephropathy may progress to end-stage renal disease.
    Salifu MO; Nicastri AD; Markell MS; Ghali H; Sommer BG; Friedman EA
    Pediatr Transplant; 2004 Aug; 8(4):351-6. PubMed ID: 15265161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact of reducing microalbuminuria in patients with type 2 diabetes mellitus.
    Araki S; Haneda M; Koya D; Kashiwagi A; Uzu T; Kikkawa R
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S54-8. PubMed ID: 18947896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The discovery of diabetic nephropathy: from small print to centre stage.
    Cameron JS
    J Nephrol; 2006; 19 Suppl 10():S75-87. PubMed ID: 16874718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB; Britton ML
    Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study.
    Costacou T; Ellis D; Fried L; Orchard TJ
    Am J Kidney Dis; 2007 Nov; 50(5):721-32. PubMed ID: 17954285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glomerular filtration rate changes in normoalbuminuric and microalbuminuric Type 2 diabetic patients and normal individuals A 10-year follow-up.
    Murussi M; Gross JL; Silveiro SP
    J Diabetes Complications; 2006; 20(4):210-5. PubMed ID: 16798471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of GFR estimation in assessment of the status of nephropathy in type 2 diabetes mellitus.
    Banerjee S; Ghosh US; Saha SJ
    J Assoc Physicians India; 2005 Mar; 53():181-4. PubMed ID: 15926598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic nephropathy: a frontier for personalized medicine.
    Susztak K; Böttinger EP
    J Am Soc Nephrol; 2006 Feb; 17(2):361-7. PubMed ID: 16407421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing microalbuminuria in patients with type 2 diabetes.
    Jermendy G; Ruggenenti P
    Diabetes Metab Res Rev; 2007 Feb; 23(2):100-10. PubMed ID: 17094161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy.
    Rossing P; Rossing K; Gaede P; Pedersen O; Parving HH
    Diabetes Care; 2006 May; 29(5):1024-30. PubMed ID: 16644632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diabetic nephropathy; clinical stage and prediction].
    Kaizu K; Komine N
    Rinsho Byori; 2001 Dec; 49(12):1205-11. PubMed ID: 11797389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic nephropathy in patients with type 1 diabetes mellitus.
    Russell TA
    Nephrol Nurs J; 2006; 33(1):15-28; quiz 29-30. PubMed ID: 16538925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic nephropathy. Prevention and early referral.
    Pylypchuk G; Beaubien E
    Can Fam Physician; 2000 Mar; 46():636-42. PubMed ID: 10752002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nephropathy in non-insulin-dependent (type-2) diabetes mellitus].
    Nagy J; Wittmann I
    Orv Hetil; 2000 Mar; 141(12):609-14. PubMed ID: 10769544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in diabetic nephropathy.
    Marshall SM
    Postgrad Med J; 2004 Nov; 80(949):624-33. PubMed ID: 15537844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.
    Haller H; Viberti GC; Mimran A; Remuzzi G; Rabelink AJ; Ritz E; Rump LC; Ruilope LM; Katayama S; Ito S; Izzo JL; Januszewicz A
    J Hypertens; 2006 Feb; 24(2):403-8. PubMed ID: 16508590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.
    Böger CA; Stubanus M; Haak T; Götz AK; Christ J; Hoffmann U; Riegger GA; Krämer BK
    Nephrol Dial Transplant; 2007 Jan; 22(1):154-62. PubMed ID: 17005529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE
    Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.